Literature DB >> 9520110

Temporal and spatial regulation of gene expression mediated by the promoter for the human tissue inhibitor of metalloproteinases-3 (TIMP-3)-encoding gene.

Y Zeng1, R C Rosborough, Y Li, A R Gupta, J Bennett.   

Abstract

A complex interplay between enzymes involved in extracellular matrix formation and their inhibitors is thought to control organogenesis during mammalian development. Disturbance of this balance may result in a wide range of diseases, including macular degeneration, arthritis, and tumor metastases. In order to define elements which may be involved in regulating human tissue inhibitor of metalloproteinase 3 (TIMP3) expression, we isolated and sequenced a clone containing 1315 bp of the 5'-upstream region of the human TIMP-3-encoding gene. A 1.2 kb fragment of this clone, which contains multiple motifs which are binding sites for known transcription factors, was used to drive expression of the lacZ reporter gene in multiple lines of transgenic mice. TIMP3 promoter activity, detected through beta-galactosidase histochemical assay, was observed at high levels in selected tissues, the identity of which varied according to developmental stage. TIMP3 promoter activity was detected at embryonic and early postnatal stages in tissues undergoing extensive remodeling, such as developing somites, bones and joints, choroid plexus, webs between the digits, and the spongiotrophoblastic portion of the placenta. In adulthood, TIMP3 promoter activity was restricted to a few tissues which exhibit high metabolic activity or rapid turnover. These include the retinal pigment epithelium (RPE), cells of the kidney cortex, hair follicles, gingiva, ovarian follicles, and testis. The results suggest that TIMP3 expression plays an active role in developmental patterning and in the maintenance of specific differentiated tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520110     DOI: 10.1002/(SICI)1097-0177(199803)211:3<228::AID-AJA4>3.0.CO;2-J

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  13 in total

1.  Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.

Authors:  C Vaillant; M Didier-Bazès; A Hutter; M F Belin; N Thomasset
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

Review 2.  Matrix remodeling during endochondral ossification.

Authors:  Nathalie Ortega; Danielle J Behonick; Zena Werb
Journal:  Trends Cell Biol       Date:  2004-02       Impact factor: 20.808

3.  Histone H3 acetylation and H3 K4 methylation define distinct chromatin regions permissive for transgene expression.

Authors:  Chunhong Yan; Douglas D Boyd
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

4.  P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3.

Authors:  Abdessamad Zerrouqi; Beata Pyrzynska; Maria Febbraio; Daniel J Brat; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

5.  Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice.

Authors:  Nina Jasmin Hewing; Gisela Weskamp; Joost Vermaat; Eric Farage; Krzysztof Glomski; Steven Swendeman; Robison Vernon Paul Chan; Michael F Chiang; Rama Khokha; Bela Anand-Apte; Carl Peter Blobel
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-30       Impact factor: 4.799

6.  Altered microRNA expression in patients with non-obstructive azoospermia.

Authors:  Jie Lian; Xiansheng Zhang; Hui Tian; Ning Liang; Yong Wang; Chaozhao Liang; Xin Li; Fei Sun
Journal:  Reprod Biol Endocrinol       Date:  2009-02-11       Impact factor: 5.211

7.  Tissue inhibitor of metalloproteinase-3 (TIMP-3) regulates hematopoiesis and bone formation in vivo.

Authors:  Yi Shen; Ingrid G Winkler; Valerie Barbier; Natalie A Sims; Jean Hendy; Jean-Pierre Lévesque
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

8.  P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice.

Authors:  May Nour; Alexander B Quiambao; Ward M Peterson; Muayyad R Al-Ubaidi; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

9.  A novel action mechanism for MPT0G013, a derivative of arylsulfonamide, inhibits tumor angiogenesis through up-regulation of TIMP3 expression.

Authors:  Chih-Ya Wang; Jing-Ping Liou; An-Chi Tsai; Mei-Jung Lai; Yi-Min Liu; Hsueh-Yun Lee; Jing-Chi Wang; Shiow-Lin Pan; Che-Ming Teng
Journal:  Oncotarget       Date:  2014-10-30

10.  Deficiency and Also Transgenic Overexpression of Timp-3 Both Lead to Compromised Bone Mass and Architecture In Vivo.

Authors:  Behzad Javaheri; Mark Hopkinson; Blandine Poulet; Andrea S Pollard; Sandra J Shefelbine; Yu-Mei Chang; Philippa Francis-West; George Bou-Gharios; Andrew A Pitsillides
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.